Fidec Corporation
Clinical trials sponsored by Fidec Corporation, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- A phase III, double-blind, randomized, placebo controlled study to evaluate the mucosal intestinal immunity to poliovirus Type-2 of nOPV2 at birth dose in healthy IPV vaccinated infants Results expected Mar 2027 (estimated)